132 related articles for article (PubMed ID: 32387838)
21. Synthesis and evaluation of new 4-oxoquinazolin-3(4H)-yl)benzoic acid and benzamide derivatives as potent antibacterial agents effective against multidrug resistant Staphylococcus aureus.
Gatadi S; Gour J; Shukla M; Kaul G; das S; Dasgupta A; Madhavi YV; Chopra S; Nanduri S
Bioorg Chem; 2019 Mar; 83():569-579. PubMed ID: 30471579
[TBL] [Abstract][Full Text] [Related]
22. N-thiadiazole-4-hydroxy-2-quinolone-3-carboxamides bearing heteroaromatic rings as novel antibacterial agents: Design, synthesis, biological evaluation and target identification.
Xue W; Li X; Ma G; Zhang H; Chen Y; Kirchmair J; Xia J; Wu S
Eur J Med Chem; 2020 Feb; 188():112022. PubMed ID: 31901744
[TBL] [Abstract][Full Text] [Related]
23. Telavancin in vitro activity against a collection of methicillin-resistant Staphylococcus aureus isolates, including resistant subsets, from the United States.
Mendes RE; Sader HS; Flamm RK; Farrell DJ; Jones RN
Antimicrob Agents Chemother; 2015 Mar; 59(3):1811-4. PubMed ID: 25561335
[TBL] [Abstract][Full Text] [Related]
24. Multidrug and vancomycin resistance among clinical isolates of
Olufunmiso O; Tolulope I; Roger C
Afr Health Sci; 2017 Sep; 17(3):797-807. PubMed ID: 29085408
[TBL] [Abstract][Full Text] [Related]
25. Synthesis and antibacterial evaluation of a novel series of synthetic phenylthiazole compounds against methicillin-resistant Staphylococcus aureus (MRSA).
Mohammad H; Reddy PV; Monteleone D; Mayhoub AS; Cushman M; Seleem MN
Eur J Med Chem; 2015 Apr; 94():306-16. PubMed ID: 25771109
[TBL] [Abstract][Full Text] [Related]
26. In Vitro activity of novel glycopolymer against clinical isolates of multidrug-resistant Staphylococcus aureus.
Narayanaswamy VP; Giatpaiboon SA; Uhrig J; Orwin P; Wiesmann W; Baker SM; Townsend SM
PLoS One; 2018; 13(1):e0191522. PubMed ID: 29342216
[TBL] [Abstract][Full Text] [Related]
27. The synthesis and antistaphylococcal activity of N-sulfonaminoethyloxime derivatives of dehydroabietic acid.
Zhang WM; Yao Y; Yang T; Wang XY; Zhu ZY; Xu WT; Lin HX; Gao ZB; Zhou H; Yang CG; Cui YM
Bioorg Med Chem Lett; 2018 Jun; 28(10):1943-1948. PubMed ID: 29650291
[TBL] [Abstract][Full Text] [Related]
28. Design and synthesis of novel anti-multidrug-resistant staphylococcus aureus derivatives of glycyrrhetinic acid by blocking arginine biosynthesis, metabolic and H
Cai DS; Yang XY; Yang YQ; Gao F; Cheng XH; Zhao YJ; Qi R; Zhang YZ; Lu JH; Lin XY; Liu YJ; Xu B; Wang PL; Lei HM
Bioorg Chem; 2023 Feb; 131():106337. PubMed ID: 36603244
[TBL] [Abstract][Full Text] [Related]
29. Oritavancin Combinations with β-Lactams against Multidrug-Resistant Staphylococcus aureus and Vancomycin-Resistant Enterococci.
Smith JR; Yim J; Raut A; Rybak MJ
Antimicrob Agents Chemother; 2016 Apr; 60(4):2352-8. PubMed ID: 26833159
[TBL] [Abstract][Full Text] [Related]
30. Unique para-aminobenzenesulfonyl oxadiazoles as novel structural potential membrane active antibacterial agents towards drug-resistant methicillin resistant Staphylococcus aureus.
Wang J; Ansari MF; Zhou CH
Bioorg Med Chem Lett; 2021 Jun; 41():127995. PubMed ID: 33775834
[TBL] [Abstract][Full Text] [Related]
31. Activities of Oxadiazole Antibacterials against Staphylococcus aureus and Other Gram-Positive Bacteria.
Ceballos S; Kim C; Ding D; Mobashery S; Chang M; Torres C
Antimicrob Agents Chemother; 2018 Aug; 62(8):. PubMed ID: 29866865
[TBL] [Abstract][Full Text] [Related]
32. Synthesis and potent in vitro activity of novel 1H-benzimidazoles as anti-MRSA agents.
Karataş H; Alp M; Yildiz S; Göker H
Chem Biol Drug Des; 2012 Aug; 80(2):237-44. PubMed ID: 22497759
[TBL] [Abstract][Full Text] [Related]
33. In vitro activity of ceftaroline and ceftobiprole against methicillin-resistant Staphylococcus aureus with decreased susceptibility to vancomycin isolated in paediatric patients.
Carnesecchi G; Lobello R; Liggieri L; Palmero C; Pescetto L; Morelli P; Castagnola E; Bandettini R
J Chemother; 2018; 30(6-8):338-341. PubMed ID: 30375268
[TBL] [Abstract][Full Text] [Related]
34. Prevalence of vancomycin-intermediate Staphylococcus aureus (VISA) and heterogeneous VISA among methicillin-resistant S. aureus with high vancomycin minimal inhibitory concentrations in Taiwan: A multicenter surveillance study, 2012-2013.
Huang SH; Chen YC; Chuang YC; Chiu SK; Fung CP; Lu PL; Wang LS; Wu TL; Wang JT
J Microbiol Immunol Infect; 2016 Oct; 49(5):701-707. PubMed ID: 26320398
[TBL] [Abstract][Full Text] [Related]
35. Antibacterial and anti-biofilm activities of thiazolidione derivatives against clinical staphylococcus strains.
Liu H; Zhao Y; Zhao D; Gong T; Wu Y; Han H; Xu T; Peschel A; Han S; Qu D
Emerg Microbes Infect; 2015 Jan; 4(1):e1. PubMed ID: 26038759
[TBL] [Abstract][Full Text] [Related]
36. Growing Resistance to Vancomycin among Methicillin Resistant Staphylococcus Aureus Isolates from Different Clinical Samples.
Pahadi PC; Shrestha UT; Adhikari N; Shah PK; Amatya R
JNMA J Nepal Med Assoc; 2014; 52(196):977-81. PubMed ID: 26982895
[TBL] [Abstract][Full Text] [Related]
37. Antagonistic Effect of Colistin on Vancomycin Activity against Methicillin-Resistant Staphylococcus aureus in
Choi S; Moon SM; Park SJ; Lee SC; Jung KH; Sung HS; Kim MN; Jung J; Kim MJ; Kim SH; Lee SO; Choi SH; Jeong JY; Woo JH; Kim YS; Chong YP
Antimicrob Agents Chemother; 2020 Mar; 64(4):. PubMed ID: 32041713
[TBL] [Abstract][Full Text] [Related]
38. Vancomycin MICs of the resistant mutants of S. aureus ATCC43300 vary based on the susceptibility test methods used.
Zhu YL; Mei Q; Hu LF; Cheng J; Ye Y; Li JB
J Antibiot (Tokyo); 2012 Jun; 65(6):307-10. PubMed ID: 22491134
[TBL] [Abstract][Full Text] [Related]
39. Synthesis and biological evaluation of rhodanine derivatives bearing a quinoline moiety as potent antimicrobial agents.
Guo M; Zheng CJ; Song MX; Wu Y; Sun LP; Li YJ; Liu Y; Piao HR
Bioorg Med Chem Lett; 2013 Aug; 23(15):4358-61. PubMed ID: 23787100
[TBL] [Abstract][Full Text] [Related]
40. Synthesis and pharmacological evaluations of 4-hydroxycoumarin derivatives as a new class of anti-Staphylococcus aureus agents.
Li ZP; Li J; Qu D; Hou Z; Yang XH; Zhang ZD; Wang YK; Luo XX; Li MK
J Pharm Pharmacol; 2015 Apr; 67(4):573-82. PubMed ID: 25556550
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]